On February 28th, 2012 the FDA issued a safety announcement alerting the public that Lipitor and other cholesterol-lowering statin drugs are associated with an increased risk for diabetes.
At that time, the FDA required safety label updates for statin drugs including warnings against “cognitive side effects (memory loss, confusion, etc.) and reports of increased blood sugar and glycosylated hemoglobin (HbA1c) levels”. While the FDA believed that the cardiovascular benefit of using statins outweighed the risk for these side effects, the Administration thought it best that the public be aware of all known risks of using these drugs.
The FDA continues, citing a study that found a 27% increased risk for diabetes among statin users, and two other studies that reported a 9% and 13% increased risk. As such, the FDA writes “Based on clinical trial meta-analyses and epidemiological data from the published literature, information concerning an effect of statins on incident diabetes and increases in HbA1c and/or fasting plasma glucose was added to statin labels.”
Sadly, the manufacturers of these drugs failed time and again to notify users of the risk for diabetes on their own, and as a result, a number of Lipitor diabetes lawsuits are currently being filed. If you or a loved one used Lipitor or another statin drug and suffered diabetes as a result, you too may be entitled to significant financial compensation.
For a free, no-obligation case consultation, contact our team of Lipitor diabetes lawyers at the information provided below. We have the compassion, resources, and experience required to win the justice you deserve.
(855) 452 – 5529
Our Lipitor Lawsuit Information page is a great place to start if you have any questions about Lipitor.